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Abstract
Background: Fusion of lumbar spine segments is a well-established therapy for many pathologies. The procedure
changes the biomechanics of the spine. Initial clinical benefits may be outweighed by ensuing damage to the
adjacent segments. Various surgical devices and techniques have been developed to prevent this deterioration.
“Topping off” systems combine rigid fusion with a flexible pedicle screw system to prevent adjacent segment
disease (ASD). To date, there is no convincing evidence that these devices provide any patient benefits.
Methods/Design: The study is designed as a randomized, therapy-controlled trial in a clinical care setting at a
university hospital. Patients presenting to the outpatient clinic with degenerative disc disease or spondylolisthesis
will be assessed against study inclusion and exclusion criteria. After randomization, the control group will undergo
conventional fusion. The intervention group will undergo fusion with a supplemental flexible pedicle screw system
to protect the adjacent segment ("topping off”).
Follow-up examination will take place immediately after treatment during hospital stay, after 6 weeks, and then
after 6, 12, 24 and 36 months. Subsequently, ongoing assessments will be performed annually.
Outcome measurements will include quality of life and pain assessments using questionnaires (SF-36™, ODI,
COMI). In addition, clinical and radiologic ASD, work-related disability, and duration of work disability will be
assessed. Inpatient and 6-month mortality, surgery-related data (e.g., intraoperative complications, blood loss,
length of incision, surgical duration), postoperative complications, adverse events, and serious adverse events will
be documented and monitored throughout the study. Cost-effectiveness analysis will also be provided.
Discussion: New hybrid systems might improve the outcome of lumbar spine fusion. To date, there is no
convincing published data on effectiveness or safety of these topping off systems. High quality data is required to
evaluate the benefits and drawbacks of topping off devices. If only because these devices are quite expensive
compared to conventional fusion implants, nonessential use should be avoided. In fact, these high costs
necessitate efforts by health care providers to evaluate the effects of these implants. Randomized clinical trials are
highly recommended to evaluate the benefits or harm to the patient.
Trial Registration: ClinicalTrials.gov: NCT01224379
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Some controversy remains regarding fusion procedures
of the lumbar spine. There is evidence that lumbar
spine fusion is more efficient than common nonsurgical
treatment [1]. On the other hand, more recent research
suggests that primary spinal fusion might not be more
beneficial than intensive rehabilitation [2]. Nonetheless,
fusion is a well-established surgical treatment for various
pathologies of the lumbar spine, and is frequently used
for patients with chronic low back pain.
Spinal fusion changes the biomechanics of the spine,
e.g., by creating increased motion in the segments adja-
cent to the fused level. Initial clinical benefits from
fusion might be outweighed by the adjacent segment
disease (ASD) that ensues. It is important to distinguish
between adjacent segment degeneration, which is a radi-
ological term and does not lead to clinical symptoms,
and adjacent segment disease. Adjacent segment disease
is the clinical presence of symptoms that correlates to
degenerative disease seen radiographically adjacent to
the index level [3].
As a result, disc arthroplasty and dynamic stabilization
techniques have evolved with the hope that the technol-
ogy can prevent this degeneration [4]. One of the most
rapidly evolving techniques in spinal surgery is posterior
dynamic stabilization (PDS). Over the past few years,
the industry has developed various types of flexible pedi-
cle screw systems, including the “topping off” technique
(a rigid system with an attached flexible system for the
adjacent segment). Other surgeons perform procedures
including a monosegmental rigid fusion plus an interspi-
nous spacer superiorly [5]. To simplify the discussion of
PDS devices, Khoueir et al. [6] classified them into:
1. Interspinous spacer devices,
2. Pedicle screw/rod-based devices, and
3. Total facet replacement systems.
The concept is to maintain or restore intervertebral
motion in a controlled fashion, whether by restricting
extremes of spinal movement or by dampening the
kinetic energy involved in motion. The goal of these
implantable devices is to mimic the behavior of the
healthy spinal column [6,7]. Companies have developed
various types of flexible pedicle screw systems (e.g. Sur-
gicraft’s Graf ligament, Bioflex’s Spring rod, Dynesys
®,
AccuFlex™, Medtronic’s Peek rod, Isobar
®) and topping
off systems (e.g. DTO™,D S S ™,C o s m i c M I A ™). Top-
ping off has been reported to provide dynamic stabiliza-
tion along with a consequent reduction of degeneration
in the adjacent segment [8,9]. Maserati et al. performed
a retrospective analysis of a population after undergoing
the topping off procedure. They concluded it was a pro-
mising alternative for multilevel fusion with the poten-
tial to avert ASD [10]. However, in a recently published,
prospective, randomized clinical trial of 60 patients
comparing fusion with a hybrid system device versus
conventional fusion over 6 years of follow-up, clinical
results did not differ between the groups (ODI, VAS,
satisfaction). Although the hybrid fixation showed less
progression of degeneration in the adjacent segment,
there was a higher rate of implant failure. This study
group did not recommend prophylactic dynamic stabili-
zation [11]. Overall, to date there is no convincing evi-
dence that these systems provide any clinical benefit
whatsoever.
It is not even clear whether the adjacent degeneration
visible radiographically is important for clinical out-
come. Fusion of spinal motor segments leads to
increased forces acting on adjacent levels and can result
in ASD. Adjacent instability is reported even 6 to 12
months post-surgery [4,12]. Average rates vary. In a ret-
rospective study, Cheh et al. identified radiographic
ASD in 42.6% of patients (average follow up 7.8 years).
Oswestry scores were worse in patients with radio-
graphic ASD. Clinical ASD developed in 43% [4]. Other
authors have reported incidence of ASD up to 24%
(average follow up 39 months). In that study, instability
developed more frequently superior to the fusion [12].
Yang et al. found a significant correlation between clini-
cal outcome and ASD [13]. In a 30-year follow-up com-
paring patients undergoing various spinal procedures
(fusion, discectomy, decompression), Kumar et al. [14]
found that the incidence of radiographic changes in
levels above the operated region was twice as high after
fusion as after the other procedures. In contrast, vali-
dated scales and functional testing (e.g. SF-36) showed
no significant differences in outcome. The author con-
cluded that radiographic changes do not necessarily lead
to functional impairment in all patients following lum-
bar spine fusion for degenerative disc disease. There is
other evidence suggesting that radiologic degeneration
of the superior adjacent segment does not correlate with
clinical results [15]. In a cohort of 215 patients after
lumbar spine arthrodesis, Ghiselli et al. reported an
adjacent segment disease rate of 16.5% after 5 years.
This rate increased to 30.1% at ten-year follow-up [16].
However, a previous review suggests that there may be a
correlation between fusion and the development of adja-
cent segment degeneration when compared to arthro-
plasty. This correlation appears even stronger when
observing adjacent segment disease, thus underscoring
the impact of fusion procedures on adjacent segments
[3].
Objective
Do topping off devices lead to better or at least equiva-
lent clinical outcomes compared to standard fusion?
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instability? Does radiographic ASD correlate with clini-
cal outcome? Does topping off lead to a higher compli-
cation rate (e.g., implant failure) than regular fusion?
Methods and Design
This study is designed as a randomized, parallel-group,
therapy-controlled trial in a clinical care setting at a uni-
versity hospital. Patients presenting to our outpatient
clinic with degenerative disc disease or spondylolisthesis
will be assessed against study inclusion and exclusion
criteria. After informed consent and randomization of
patients, surgery will be performed. Follow-up examina-
tions will take place immediately after treatment during
hospital stay, and then after another 6 and 24 weeks, for
a total study duration of 6 months. Data will be assessed
after 12, 24, and 36 months for a supplemental investi-
gation. Further assessments will be performed annually,
to account for the possibility that conclusions regarding
ASD might not be definitive after 36 months.
Experimental research in this trial will be performed
with the approval of the ethics committee of the medical
faculty of the University of Cologne under the reference
number 10-259. Research carried out in the trial will be
in compliance with the Helsinki Declaration [17].
Participants and recruitment
Patients over 30 years of age presenting to our outpati-
ent clinic with degenerative disc disease or spondylo-
listhesis and indications for monosegmental lumbar
spine fusion are eligible for trial inclusion. Surgery will
not be considered until at least 6 months of conservative
treatment have been concluded. Patients with spondylo-
listhesis must respond positively to facet joint injection.
Radiologic inclusion criteria are summarized in the
appendix.
Prerequisite to inclusion is the presence of radiologic
degeneration of the adjacent segment (Pfirrmann grades
II-IV in MRI findings [18]) without signs of instability.
Definition of radiologic and clinical instability as well as
further inclusion criteria are summarized in the
appendix.
Study subjects will be approached and recruited by
experienced spine surgeons. For the screening proce-
dure, an estimated 150 patients per year will undergo
primary monosegmental fusion within the department.
Recruitment of approximately 30 patients per year is
anticipated.
Patients participating in parallel interventional studies
as well as patients with lumbar scoliosis (> 25° cobb
angle), spondylolisthesis Meyerding IV, and/or radiologic
ASD worse than Fujiwara grade II or Pfirrmann grade
IV [18,19] are excluded from this study. Further exclu-
sion criteria are summarized in the appendix.
Interventions
▪ Patients will receive one of two treatments:
▪ Conventional monosegmental posterior lumbar
intervertebral fusion (PLIF)
▪ Hybrid system (PLIF + flexible pedicle screw sys-
tem above the fusion)
Control group - conventional PLIF
The control group will receive a monosegmental poster-
ior lumbar spine fusion with an intervertebral cage
(PLIF). This is the current, well-established therapy for
several pathologies of the lumbar spine (e.g. spondylo-
listhesis, degenerative disc disease). Thus, the control
group will receive the standard of care. This is the only
acceptable control/comparis o ni nat r i a lo ft h i sk i n d .
Surgery will be performed using the following devices:
Optima ZS™ (Zimmer
® Spine Germany GmbH, Kiel,
Germany), Wave
© Lumbar Cage (Advanced Medical
Technologies AG, Nonnweiler, Germany)
Intervention group - hybrid system
The intervention group will receive a hybrid system with
PLIF and a flexible pedicle screw system above the
fusion. Surgery will be performed using the following
devices: Optima ZS™+D T O ™ (Zimmer
® Spine Ger-
many GmbH, Kiel, Germany), Wave
© Lumbar Cage
(Advanced Medical Technologies AG, Nonnweiler,
Germany)
Only skilled spine surgeons (with minimum experi-
ence of 30 fusion procedures) will participate in the
trial. Intraoperative photo documentation will assist in
preventing variations of the procedure (e.g., enlargement
of decompression/approach). We will also provide an
instructional movie on the procedural standards as well
as evaluation of the x-rays.
All patients will receive a surgical drain, to be
removed 2 days post-surgery. Both groups of patients
will receive physical therapy, beginning on the day after
surgery. Patients will be discharged only after sufficient
convalescence with unremarkable wound healing. Hospi-
tal admission lasting 8-10 days will be necessary. Physi-
cal therapy will be performed during the inpatient
period. After hospital discharge, physical therapy will be
continued under outpatient conditions. This therapy will
not be standardized in order to reflect reality.
Outcome measures and assessments
Primary Outcome Measures
The focus of this investigation is on subjective and
objective clinical benefits for the patient. Functional out-
comes will be evaluated using the SF-36™ score after 6
weeks as well as 6, 12, 24, and 36 months after surgery.
The SF-36™ is the most frequently used generic health
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investigations have focused on technical outcomes; how-
ever, more recently they have turned to clinical results
[20,21]. It is unclear whether radiologic parameters cor-
relate with clinical success; thus, they are poor measures
of primary outcome. Recent, important randomly con-
t r o l l e dt r i a l s( R C T s )i ns p i ne surgery have used the SF-
36™ and ODI tools to assess clinical outcomes [22,23].
Parameters like pain and walking distance are repre-
sented in the SF-36. The development of physical (PCS)
and mental health (MCS) component scores has eased
interpretation and cross-cultural comparison of the SF-
36™.T h eS F - 3 6 ™ is a standardized questionnaire to
detect patient quality of life corresponding to conditions
of health. It yields an 8-scale profile of functional health
and well-being scores, as well as psychometrically-based
physical and mental health summary measures, and a
preference-based health utility index. Thus, the SF-36™
and the patient responses contained within are a good
measure of primary endpoint. Points are awarded for
individual answers by each patient and added to yield a
sum total. The SF-36™ PCS scores of the experimental
and control groups will be compared to further quantify
patient outcome. Subsequent follow-up will repeat the
SF-36™ to ensure assessment for clinical impairment
and/or the manifestation of a clinical or radiologic
instability. This follow-up will continue for up to 3 years
and further after treatment. In cases of impairment, x-
ray is medically indicated at any point of time.
Secondary Outcome Measures
1. Total, MCS, and 8 individual dimensions and sub-
scales of the SF-36™ (version 4.0) for confirmation and
clarification of the primary outcome results.
2. ODI (cross-cultural adaption of the ODI version 2.1
for use with German-speaking patients)[24]: this is one
of the condition-specific questionnaires recommended
for use with back pain patients. The ODI is a standar-
dized, patient-completed questionnaire which gives a
subjective percentage score of level of function (disabil-
ity) in activities of daily living for those rehabilitating
from low back pain. The questionnaire examines per-
ceived level of disability in 10 everyday activities of daily
living.
3. COMI questionnaire (version 2008): a patient-
oriented, short, multidimensional outcome instrument
validated for patients with spinal disorders.
4. X-rays will be taken after 6 weeks, 6, 12, 24, and 36
months. Further assessments will be performed annually.
These are common intervals after surgical implant pro-
cedures not requiring extraneous radiation. At the point
in time where adjacent instability is identified radiogra-
phically, we will reevaluate and compare the clinical
outcome. Criteria for radiologic ASD as well as adjacent
instability are listed in the appendix (definition of
radiologic instability and Weiner’s classification). Pre-
and postoperative x-rays must be compared to assess
the Weiner’s classification score. X-rays will be evalu-
ated by experienced radiologists.
5. Clinical ASD will be assessed (see appendix for the
definition).
6. Work-related function/disability at the time of sur-
gery and after surgery, plus the duration until return to
work. At each visit, patients will be interviewed about
their level of work-related function/disability as well as
the time point when/if they return to employment.
7. Inpatient mortality and mortality at 6 months.
8. Surgery-related data (blood loss, length of incision,
duration of surgery) are taken from the surgical report.
9. Intraoperative and postoperative complication rates
(e.g. implant failure)
10. Adverse events (AE) and serious adverse events
(SAE) will be documented and monitored throughout
the study.
Sample size
Our target recruitment is 30 patients. We assume a loss
of follow-up of 10%, so that 27 patients should be avail-
able for the final analysis. The normalized form of the
SF-36™ PCS (mean 50, standard deviation 10) is
assumed. With this number of patients, using a two-
sided t-test, a normalized PCS score difference of 11.2
or more could be detected with a power of 80% and
alpha = 0.05.
Randomization
The randomization of patients into intervention and
control groups will be performed using blocks of ran-
domly variable length in order to maintain balance
while preventing predictability of allocation. Randomiza-
tion is stratified by surgeon. A container with the
sequentially numbered, sealed envelopes is stored in a
locked cupboard, which only the investigator(s) can
open. The random allocation sequence and the sealed
envelopes will be generated by the Institute of Medical
Statistics, Informatics, and Epidemiology of the univer-
sity conducting the trial. Enrollment and randomization
will be executed by the investigator.
Data analysis
The PCS and MCS sub-scores and the ODI score are
measured repeatedly; thus, areas under the curve (AUC)
will be computed. AUCs will be compared between
treatment groups using a two-sample t-test.
Time until ASD or adjacent segment instability will be
analyzed using the life-table method and compared
between treatment groups using the log-rank test.
The primary analysis set is defined according to the
intention-to-treat principle, including all randomized
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Robustness of results will be investigated by additional
analyses based on the per-protocol set. Interim analyses
are not foreseen.
Cost-effectiveness analysis
For our analysis, both a hospital and a societal perspec-
tive will be used. Because the surgical treatments to be
analyzed do not differ in their DRG-codes, the costs for
the hospital will be estimated based on differences in
costs of implants used for the surgery and length of hos-
pital stay. Cost-benefit is then expressed as cost per
reduced length of stay.
For the societal perspective, additional resource utili-
zation after discharge from hospital will be assessed
based on a patient diary. After being discharged from
the hospital, the patient will report direct medical costs
such as those from physiotherapy, visits to general prac-
titioners or specialists, and surgery-related medication
(e.g., analgesics). Additionally, indirect costs from work
absences will be recorded. For data on efficacy, quality-
adjusted life years (QALY) are estimated by using the
SF-36
® Health Survey, a generic outcome measure
designed to examine a person’s perceived health status.
An incremental cost-effectiveness ratio in terms of costs
per QALY will be calculated.
Discussion
New hybrid systems might improve the outcome of
lumbar spine fusion. To date, however there is no con-
vincing published data regarding these topping off sys-
tems. High quality data is required to provide a
preliminary impression of the advantages and disadvan-
tages of such devices. If only because topping off devices
are quite expensive compared to conventional implants,
nonessential use should be avoided. In fact, these high
costs necessitate efforts by health care providers to
examine the effects of these implants. Randomized clini-
cal trials are highly recommended to evaluate the bene-
fits or harm to patients.
In the intervention group, the approach to the spine
will be enlarged compared to that of the monosegmental
fusion group. The longer approach itself could bring
about a negative outcome compared to that of regular
fusion (e.g., due to muscle damage, blood loss, higher
risk of infection). As well, implant failure rates can be
compared between the groups. The crucial question,
however, is the ability to prevent ASD.
Placebo is not an acceptable option for the control
group for fundamentally ethical reasons. Not only would
such an option deprive the patient of adequate treat-
ment, but also to have a realistic placebo would require
an invasive procedure without the implantation of a
medical device, thus exposing him/her to significant
risks without providing benefit. Furthermore, a “placebo
device” as replacement for the respective topping-off
system does not exist.
Appendix
Inclusion criteria
￿ Informed consent
￿ Legal capacity
￿ Age ≥ 30 years
￿ Indication for monosegmental lumbar spine fusion
(PLIF or “topping-off “) L2-S1 with osteochondrosis
Modic grades I-III [25-27] or spondylolisthesis
Meyerding grades I-III.
￿ Radiologic signs of degeneration in the adjacent
segment of the intended fusion without signs of
instability
￿ Definition of adjacent segment degeneration (MRI)
Pfirrmann [18] grades II-IV (Figure 1)
Definition of radiologic instability (x-ray: a.p. and
lateral views, extension and flexion):
Figure 1 Decision tree of disc degeneration according to
Pfirrmann et al. 2001 [18].
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translation) [4]
2. Segmental kyphosis > 10° [4]
3. Rotatory hypermobility > 15° [12]
4. Complete collapse of the disc [4]
5. Lateral translation > 3 mm [12]
6. Disc Wedging > 5° [12]
7. Deterioration in the Weiner’s classification of 2 or
more grades in the follow-up evaluation [1,27]
Weiner’s classification [28]
0 = No disease, defined by normal disc height, no
spur formation, no eburnation, and no gas
1 = Mild disease, defined by < 25% disc space nar-
rowing, small spur formation, minimal eburnation,
and no gas
2 = Moderate disease, defined by 25%-75% disc
space narrowing, moderate spur formation, moderate
eburnation, and no gas
3 = advanced disease, defined by > 75% disc space
narrowing, large spur formation, marked eburnation,
gas present
Exclusion criteria
￿ Motor deficit
￿ Cauda equina syndrome
￿ Previous surgical intervention of the lumbar spine
￿ Relevant peripheral neuropathy
￿ Acute denervation subsequent to radiculopathy
￿ Scoliosis with Cobb angle greater than 25°
￿ Spondylolisthesis > Meyerding grade III
￿ Radiologic signs of degeneration in the adjacent seg-
ment of the intended fusion with signs of instability (for
definition, see inclusion criteria)
￿ No radiologic signs of degeneration in the adjacent
segment of the intended fusion (for definition, see inclu-
sion criteria)
￿ Radiologic signs of degeneration in the adjacent seg-
ment of the intended fusion with > Fujiwara grade II
[19] or > Pfirrmann grade IV [18]
￿ Signs of instability in any lumbar spine segment
other than that undergoing fusion
￿ General contraindication for elective lumbar spine
surgery
￿ Pathologic fracture
￿ Osteoporosis with pathologic fracture
￿ Active systemic infection
￿ Rheumatic disease
￿ Disease of bone metabolism (e.g. Paget’s disease)
￿ Bone metastasis
￿ Local infection focus lumbar spine
￿ Seizure disorder
￿ Chronic ischemia Fontaine classification IIb-IV
￿ Severe heart insufficiency (NYHA III-IV)
￿ Blood coagulation disorder or blood thinning
therapy
￿ Cortisone intake longer than one month in the 12
months prior to randomization
￿ Simultaneous participation in another clinical trial in
the 30 days before randomization
￿ Known allergy or intolerance to the implants
￿ Dependency on investigator
￿ Lack of familiarity with the German language
￿ Placement in an institution by governmental or judi-
cial advice
￿ Absent legal capacity
￿ Pregnancy
Definition of clinical ASD [12]
1. Symptomatic spinal stenosis
2. Mechanical back pain
3. Sagittal or coronal imbalance
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